AngioDynamics is a provider of minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology. Navilyst Medical focuses on technologies for the vascular system.
The transaction is valued at $355 million. The combination of the companies is expected to double AngioDynamics share of the vascular access market.
“Today is an important day for AngioDynamics’ customers, shareholders and employees,” said Joseph DeVivo, president and CEO of AngioDynamics, in the release. “We are a stronger and more competitive company as a result of scale, technology and talent gained by this acquisition. Our integration plan is underway and we are excited to begin creating the new AngioDynamics.”
Related Articles on Company Acquisitions:
Cardinal Health to Acquire Dik Drug
Omnicell to Acquire MTS Medication Technologies
Ansell Completes Acquisition of Trelleborg Protective Products
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.